SCHEMBL4659580

SCHEMBL4659580

CCCC(CN)C(C)(C)C

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.33
TDP1 Q9NUW8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4857614 0.84 ALDH1A1 (0.46) ALDH1A1TDP1
SCHEMBL1165012 0.82 OPRM1 (0.42) ALDH1A1TDP1
SCHEMBL6037285 0.82 TSHR (0.33) TDP1
SCHEMBL23707746 0.79 ALDH1A1 (0.31) ALDH1A1TDP1
SCHEMBL23104697 0.79 ALDH1A1 (0.31) ALDH1A1TDP1
SCHEMBL6736147 0.78
SCHEMBL598909 0.77 TSHR (0.36)
SCHEMBL2627104 0.77
SCHEMBL24741005 0.76 RIPK1 (0.31)
SCHEMBL28960640 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2004193-A2 OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION Merck & Co., Inc. (US) 2008-12-24 EP disclosed
WO-2007108968-A2 OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION MERCK & CO., INC. (US) 2007-09-27 WO disclosed